Trial Profile
A multi-centre, prospective, non-interventional study of a basal insulin investigating the safety and effectiveness in a real world population with type 1 and 2 diabetes mellitus
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novo Nordisk
- 08 Apr 2015 New trial record